Hosted on MSN11mon
BIOLASE (BIOL) Price Target Decreased by 19.68% to 11.45BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for ...
BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.
StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a research report report published on Tuesday. The brokerage issued a sell rating on the medical technology company ...
YAG lasers for cutting soft tissue. But in the late 1990s, companies like Biolase in Irvine, California, gained approval from the US Food and Drug Administration (FDA) for Er,Cr:YSGG lasers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results